Literature DB >> 10967244

Activation of pig oocytes using calcium ionophore: effect of protein synthesis inhibitor cycloheximide.

F Jílek1, R Hüttelová, J Petr, M Holubová, J Rozinek.   

Abstract

In vitro matured pig oocytes were activated using a combined treatment of calcium ionophore A 23187 with cycloheximide. The oocytes were exposed to ionophore (10, 25 or 50 microM) for 0.5, 1, 3, 5 or 7 min and then cultured with cycloheximide (0 or 10 microg/ml) for 6 h. Cycloheximide treatment significantly increased the activation rate of oocytes and the percentage of oocytes that were able to develop after activation. The highest activation rate was observed after treatment with 50 microM ionophore. The highest percentage of developing eggs was observed after combined treatment of ionophore (25 microM) with cycloheximide. The percentage of oocytes developing up to the morula and blastocyst stage was not significantly increased after cycloheximide treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967244     DOI: 10.1016/s0378-4320(00)00150-0

Source DB:  PubMed          Journal:  Anim Reprod Sci        ISSN: 0378-4320            Impact factor:   2.145


  3 in total

1.  An insufficient increase of cytosolic free calcium level results postovulatory aging-induced abortive spontaneous egg activation in rat.

Authors:  Karuppanan V Premkumar; Shail K Chaube
Journal:  J Assist Reprod Genet       Date:  2012-12-14       Impact factor: 3.412

2.  Degradation of retinoid X receptor alpha by TPA through proteasome pathway in gastric cancer cells.

Authors:  Xiao-Feng Ye; Su Liu; Qiao Wu; Xiao-Feng Lin; Bing Zhang; Jia-Fa Wu; Ming-Qing Zhang; Wen-Jin Su
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

3.  Roles of PLC-gamma2 and PKCalpha in TPA-induced apoptosis of gastric cancer cells.

Authors:  Bing Zhang; Qiao Wu; Xiao-Feng Ye; Su Liu; Xiao-Feng Lin; Mu-Chuan Chen
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.